Diabetes Treatment and Prevention Market which is Expected to Grow at a CAGR Of 4.86% From 2025 To 2035

Pune, India, July 2022 /MRFR Press Release/- Market research future has a half cooked research report on BRICS diabetes treatment and prevention Market. The BRICS market for diabetes treatment and prevention is growing continuously and expected to grow at a CAGR of 4.86% from 2025 to 2035

BRICS Diabetes Treatment And Prevention Market Report Highlights

Diabetes drugs are the drugs which are administered for the treatment of different types of Diabetes. The prevalence of diabetes is on the rise due to increased life expectancy, changing lifestyles, and the rising incidence of obesity. Diabetes can be kept in control with the help of medication, exercise and controlled diet. BRICS Diabetes treatment and prevention market is expected to reach USD 12.4 Million by 2035 at a CAGR of 4.86% during forecast period 2025 to 2035.

Test the market data and market information presented through more than 45 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Diabetes treatment and prevention market Research Report –BRICS Forecast to 2030.”

BRICS diabetes treatment and prevention market players:Key players in diabetes treatment and prevention market are: Abbott Laboratories (U.S), Bayer AG (Germany), Eli Lily & Company (U.S), Medtronic (U.S), AstraZeneca Plc. (U.K), Lifescan (U.S), Terumo Medical Corporation (Japan) and Roche Holding AG (Switzerland).Bayer AG is a chemical, pharmaceutical and life science company. It is one of the major players manufacturing drugs for diabetes.Eli Lilly and Company is an American BRICS pharmaceutical company with headquarters located in Indianapolis, Indiana, in the United States. The company also has offices in Puerto Rico and 17 other countries. Its products are sold in approximately 125 countries. In January, 2017, the Eli Lilly Company was awarded as world’s most ethical company.

Figure 1          Major players in the BRICS diabetes treatment and prevention market, 2016

Segmentation:Figure 2   BRICS diabetes treatment and prevention market, by type, 2016 (%) 

BRICS diabetes treatment and prevention market has been segmented on the basis of type of diabetes which includes type 1 diabetes, type 2 diabetes and gestational diabetes. On the basis of treatment the market is segmented into medication, gene therapy, other methods of treatment and devices include Blood Glucose Meters and Strips, Continuous Glucose Monitors (CGMs), Injection Pens, Insulin Pump, others. On the basis of end users the market is segmented into hospitals, clinics, pharmaceutical companies and other end users.